Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

356
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
356
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

1.8K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.8K
Stress and Mental Health01:30

Stress and Mental Health

1.6K
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
1.6K
Stimulants01:29

Stimulants

1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.4K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatty acid ethyl esters in meconium and language development at 10 and 12 years.

Pediatric research·2026
Same author

Intergenerational transmission of maternal childhood maltreatment, prenatal substance exposure, and internalizing and externalizing symptoms in early adolescence at age 12.

Journal of child psychology and psychiatry, and allied disciplines·2025
Same author

Cognitive and behavioral pathways from prenatal cocaine exposure to regular marijuana use during emerging adulthood.

Drug and alcohol dependence·2025
Same author

The relationships of prenatal cocaine exposure, postnatal lead exposure, and victimization to aggressive behavior/delinquency in adolescence.

Neurotoxicology and teratology·2025
Same author

Maternal Childhood Trauma and Children's Developmental Course of Aggressive Behavior from Ages 4 to 12.

Psychology of violence·2025
Same author

Internal assets in low-income urban adolescents from 12 to 17 years: Gender variation.

Journal of research on adolescence : the official journal of the Society for Research on Adolescence·2025
Same journal

Diagnosis and Treatment of Kaposi's Sarcoma.

Resident and staff physician·2022
Same journal

Cardiac Complications of Myeloproliferative Disorders.

Resident and staff physician·2022
Same journal

Hematological Complications of Acute Pancreatitis: A Review.

Resident and staff physician·2021
Same journal

Henoch-Schönlein Purpura Presenting as a Rash and Proteinuria in a 59-Year-Old Woman.

Resident and staff physician·2021
Same journal

Hypoparathyroidism.

Resident and staff physician·2021
Same journal

Sjogren's syndrome and Lymphoma.

Resident and staff physician·2021
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.5K

Medical and Psychologic Risks of Maternal Cocaine Use.

Lynn Singer1, Robert E Arendt2, Sonia Minnes3

  • 1Departments of Pediatrics and Psychiatry, Case Western Reserve University School of Medicine; Director, Center for the Advancement of Mothers and Children at Metro Health Medical Center, Cleveland, OH.

Resident and Staff Physician
|January 9, 2015
PubMed
Summary
This summary is machine-generated.

Maternal crack-cocaine use negatively impacts pregnancy and infant health, leading to complications like low birth weight. Further research is needed on neurobehavioral outcomes for cocaine-exposed infants.

More Related Videos

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.9K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

826

Related Experiment Videos

Last Updated: Apr 18, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.5K
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.9K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

826

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Addiction Medicine

Background:

  • Increasing prevalence of crack-cocaine use among women of childbearing age presents clinical challenges.
  • Cocaine exposure during pregnancy is linked to adverse maternal and infant outcomes.

Purpose of the Study:

  • To review the effects of maternal crack-cocaine use on pregnancy and infant development.
  • To highlight the need for physician education on managing drug-exposed pregnancies.

Main Methods:

  • Review of existing animal and human studies on cocaine's effects during pregnancy.
  • Analysis of documented maternal complications and infant outcomes.

Main Results:

  • Maternal cocaine use is associated with pregnancy complications and increased rates of low birth weight and prematurity.
  • Neurobehavioral outcomes in cocaine-exposed infants remain inconclusive.

Conclusions:

  • Physicians require enhanced knowledge regarding maternal drug addiction during pregnancy for optimal patient care.
  • Understanding the multifaceted impact of cocaine on maternal-fetal health is crucial.